menu

Non-Opioid Pain Treatment Market

Schedule Call

Non-Opioid Pain Treatment Market

Non-Opioid Pain Treatment Market by Drug Class (NASIDs, Acetaminophen), Pain Type (Chronic Pain, Post-operative Pain, Cancer Pain), Route of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Global Outlook & Forecast 2023-2031

GR - 484867 Category: Pharmaceuticals

Number of pages: 100  |  Report Format: PDF  |  Published date: March 17, 2023

Historical Years – 2021  |  Base Year – 2022  |  Forecasted Years – 2023-2031


Non-Opioid Pain Treatment Market Scope

Report Attribute

Details

Market Size Value in 2022

US$ 38.77 billion

Revenue forecast in 2031

US$ 79.46 billion

CAGR

8.3%

Base Year for Estimation

2022

Forecast Period

2023-2031

Historical Year

2021

Segments Covered

Drug Class, Pain Type, Route of Administration, Distribution Channel, and Region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global non-opioid pain treatment market was valued at US$ 38.77 billion in 2022 and is expected to register a revenue CAGR of 8.3% to reach US$ 79.46 billion by 2031.

Non-opioid Pain Treatment Market Fundamentals

Non-opioid pain treatment is a category of pain management methods that do not involve using opioids, which can be highly addictive and have significant potential for abuse. Various non-opioid pain treatment options are available that can effectively manage pain and improve the quality of life for individuals with chronic pain conditions. One commonly used non-opioid pain treatment is acetaminophen, often used to relieve mild to moderate pain. Additionally, topical creams and ointments are another non-opioid pain treatment option that can relieve localized pain and inflammation. Antidepressants and anticonvulsants are traditionally used to treat depression and epilepsy. However, they can also effectively manage certain types of chronic pain. Physical therapy is another non-opioid pain treatment that can be used to manage chronic pain. Moreover, transcutaneous electrical nerve stimulation is another non-opioid pain treatment that involves the application of a mild electrical current to the skin to help relieve pain. 

[58565]

Non-opioid Pain Treatment Market Dynamics

The rising incidence of chronic diseases is expected to fuel the expansion of the non-opioid pain treatment market. Increased expenditure on research and development, clinical studies, and changes in the regulatory environment, thus, enhancing support for various non-opioid medications, helping the non-opioid pain treatment market to expand.

The non-opioid pain treatment market is predicted to grow due to a modernized development route for non-opioid analgesics and collaboration among key producers for medication development. Furthermore, rapidly growing cases of diseases, such as cancer, arthritis, etc., leading to chronic pain conditions, such as migraine, osteoarthritis, lower back pain, and localized musculoskeletal pain, are driving the global non-opioid pain treatment market revenue growth. 

The opioid epidemic is a major public health concern in many countries, leading to increased scrutiny of opioid use for pain management. Advances in medical technology have also led to the development of new non-opioid pain treatment options, including new drug formulations, devices, and therapies. Governments and regulatory bodies are increasingly promoting non-opioid pain treatment options, which has led to increased investment in research and development in this market. This resulted in enhanced awareness of the benefits of non-opioid pain treatment. Healthcare spending is increasing globally, driven by population growth, aging, and the increasing burden of chronic diseases, leading to increased investment in non-opioid pain treatment research and development.

However, the treatment’s negative effects may limit market expansion throughout the forecast period. NSAIDs are often used to treat pain in the elderly. Many studies have shown that long-term NSAID usage increases the risk of heart failure, myocardial infarction, stroke, and peptic ulcers, limiting market expansion.

Non-opioid Pain Treatment Market Ecosystem

The global non-opioid pain treatment market has been analyzed from five perspectives: drug class, pain type, route of administration, distribution channel, and region.

Non-Opioid Pain Treatment Market by Drug Class

[56556]

Based on drug class, the global non-opioid pain treatment market can be further segmented into NASIDs, acetaminophen, local anesthetics, and others.

The NASIDs segment dominates the global non-opioid pain treatment market with the largest revenue share due to its higher sales rate. NSAIDs are widely available and can be purchased over the counter in many countries. Additionally, NSAIDs effectively relieve mild to moderate pain and reduce inflammation. They work by blocking the production of prostaglandins, which are responsible for causing pain and inflammation. NSAIDs are generally inexpensive compared to other non-opioid pain treatment options, attracting many individuals and healthcare providers. NSAIDs are available in various formulations, including tablets, capsules, creams, gels, and patches, making them a versatile option for managing different types of pain. NSAIDs are not addictive and do not have the potential for abuse, which makes them a safer choice than opioids for long-term pain management. NSAIDs have been used for decades and have an established safety profile, which has helped to build trust among healthcare providers and patients.

Non-Opioid Pain Treatment Market by Pain Type

Based on pain type, the global non-opioid pain treatment market can be further segmented into chronic pain, post-operative pain, cancer pain, and others.

The chronic pain segment accounts for the largest revenue share in the global market. The growth of this segment can be ascribed to the rising incidence of chronic pain, such as neuropathic pain and pain associated with inflammatory disorders, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and others, as well as the increased need for non-opioid analgesic medications. Thus, the rising incidence of illnesses is expected to boost the number of NSAID prescriptions.

Non-Opioid Pain Treatment Market by Route of Administration

Based on the route of administration, the global non-opioid pain treatment market can be further segmented into oral, injectable, topical, and other. 

The oral segment accounts for the greatest revenue share in the global market. Oral medications are less difficult to administer than topical and injectable medications. Patients can administer the tablets or capsules themselves, eliminating the need for frequent visits to the healthcare facility for treatment operations. Furthermore, oral medications can function throughout the body and have systemic effects. This can be advantageous for those undergoing non-opioid pain management. Oral medications have been demonstrated to be beneficial in treating non-opioid pain. These factors contribute to expanding the oral route segment, propelling the global market.

The injectable segment is expected to show significant revenue growth during the forecast period. This can be ascribed to technological advancements in drug delivery, the commercialization of novel IV products, and the increasing usage of local anesthetic products for surgical procedures. 

Non-Opioid Pain Treatment Market by Distribution Channel

Based on the distribution channel, the global non-opioid pain treatment market can be further segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Hospital pharmacies play a significant role in treating non-opioid pain treatment and are important contributors to the growth of the non-opioid pain treatment market. Hospital pharmacies can provide patients with a broader selection of pharmaceuticals, including biologics, that may not be available in other settings. This can assist in guaranteeing that patients receive the best therapy possible for their illnesses. Furthermore, hospital pharmacies may collaborate closely with other healthcare professionals to provide patients with coordinated and tailored care for non-opioid pain therapy. This can lead to improved treatment results and patient satisfaction. Furthermore, hospital pharmacies may monitor patients’ drugs and help with side effects and other concerns that may emerge during therapy. This can assist in guaranteeing that patients receive the best possible care and that treatment outcomes improve. Additionally, these pharmacies can participate in clinical studies and other non-opioid pain management research. This can help create novel medicines and therapies for the condition, benefiting patients and boosting market revenue growth. 

Non-Opioid Pain Treatment Market by Region

Based on the region, the global non-opioid pain treatment market can be further segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America accounted for the largest revenue share in the non-opioid pain treatment market, and this trend is expected to continue throughout the forecast period. This is due to significant key market players and the rise in non-opioid pain treatment patients in the United States. Additionally, the region’s high disposable income has propelled the development of the healthcare industry owing to the affordability of investing in highly sophisticated medicine that matches the specific medical needs of the people, which further propels market expansion in the region.

Asia Pacific is predicted to have the fastest revenue CAGR throughout the forecast period due to a growth in the number of major companies producing non-opioid pain treatment products, an increase in the incidence of chronic diseases (such as cancer and arthritis), and a rise in the population of countries, such as India, China, and Japan, which are more vulnerable to chronic pain diseases. Furthermore, increasing government efforts to raise public awareness about the detrimental repercussions of long-term psoriasis boosts market revenue growth in the region.

Non-opioid Pain Treatment Market Competitive Landscape

The prominent players operating in the global non-opioid pain treatment market are:

Non-opioid Pain Treatment Market Strategic Developments

  • In June 2022, the US Food and Drug Administration (FDA) provided Stride Pharma’s ibuprofen suspension ANDA competitive generic treatment exclusivity for 180 days. This ibuprofen suspension treats various pain disorders, including tooth pain, muscular pains, arthritis, and headaches.
  • In February 2021, the US FDA approved the first and only acetaminophen injection developed by B Braun Medical to treat pain conditions caused by various diseases
  • In March 2020, US FDA approved Advil Dual Action for treating patients with dental pain. This drug was a combination of acetaminophen and ibuprofen to be available over the counter for dental patients in the United States.

Frequently Asked Questions About This Report

The global non-opioid pain treatment market is expected to grow at a revenue CAGR of 8.3% during the forecast period.

Cipla Inc., Johnson & Johnson Services Inc., Pacira Pharmaceuticals Inc., and Pierrel are among the key players in the global non-opioid pain treatment market.

The NASIDs segment dominates the global non-opioid pain treatment market.

Asia Pacific is expected to observe the highest revenue growth in the global non-opioid pain treatment market during the forecast period.

The global non-opioid pain treatment market was valued at US$ 38.77 billion in 2022.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
  5. GLOBAL NON-OPIOID PAIN TREATMENT MARKET- ANALYSIS & FORECAST, BY DRUG CLASS
    1. NSAIDs
      1. Selective COX-2 Inhibitors
      2. Non-Selective NSAIDs
    2. Acetaminophen
    3. Local Anesthetics
    4. Others
  6. GLOBAL NON-OPIOID PAIN TREATMENT MARKET- ANALYSIS & FORECAST, BY PAIN TYPE
    1. Chronic Pain
      1. Neuropathic Pain
      2. Inflammatory Conditions
    2. Post-operative Pain
    3. Cancer Pain
    4. Others
  7. GLOBAL NON-OPIOID PAIN TREATMENT MARKET- ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
    1. Oral
    2. Injectable
    3. Topical
    4. Others
  8. GLOBAL NON-OPIOID PAIN TREATMENT MARKET- ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  9. GLOBAL NON-OPIOID PAIN TREATMENT MARKET- ANALYSIS & FORECAST, BY REGION
    1. North America Non-Opioid Pain Treatment Market
      1. North America Non-Opioid Pain Treatment Market, by Drug Class
      2. North America Non-Opioid Pain Treatment Market, by Pain Type
      3. North America Non-Opioid Pain Treatment Market, by Route of Administration
      4. North America Non-Opioid Pain Treatment Market, by Distribution Channel
      5. North America Non-Opioid Pain Treatment Market, by Country
        1. U.S.
          1. U.S. Non-Opioid Pain Treatment Market, by Drug Class
          2. U.S. Non-Opioid Pain Treatment Market, by Pain Type
          3. U.S. Non-Opioid Pain Treatment Market, by Route of Administration
          4. U.S. Non-Opioid Pain Treatment Market, by Distribution Channel
        2. Canada
          1. Canada Non-Opioid Pain Treatment Market, by Drug Class
          2. Canada Non-Opioid Pain Treatment Market, by Pain Type
          3. Canada Non-Opioid Pain Treatment Market, by Route of Administration
          4. Canada Non-Opioid Pain Treatment Market, by Distribution Channel
    2. Europe Non-Opioid Pain Treatment Market
      1. Europe Non-Opioid Pain Treatment Market, by Drug Class
      2. Europe Non-Opioid Pain Treatment Market, by Pain Type
      3. Europe Non-Opioid Pain Treatment Market, by Route of Administration
      4. Europe Non-Opioid Pain Treatment Market, by Distribution Channel
      5. Europe Non-Opioid Pain Treatment Market, by Country/Region
        1.  Germany
          1. Germany Non-Opioid Pain Treatment Market, by Drug Class
          2. Germany Non-Opioid Pain Treatment Market, by Pain Type
          3. Germany Non-Opioid Pain Treatment Market, by Route of Administration
          4. Germany Non-Opioid Pain Treatment Market, by Distribution Channel
        2. U.K.
          1. U.K. Non-Opioid Pain Treatment Market, by Drug Class
          2. U.K. Non-Opioid Pain Treatment Market, by Pain Type
          3. U.K. Non-Opioid Pain Treatment Market, by Route of Administration
          4. U.K. Non-Opioid Pain Treatment Market, by Distribution Channel
        3. France
          1. France Non-Opioid Pain Treatment Market, by Drug Class
          2. France Non-Opioid Pain Treatment Market, by Pain Type
          3. France Non-Opioid Pain Treatment Market, by Route of Administration
          4. France Non-Opioid Pain Treatment Market, by Distribution Channel
        4. Spain
          1. Spain Non-Opioid Pain Treatment Market, by Drug Class
          2. Spain Non-Opioid Pain Treatment Market, by Pain Type
          3. Spain Non-Opioid Pain Treatment Market, by Route of Administration
          4. Spain Non-Opioid Pain Treatment Market, by Distribution Channel
        5. Italy
          1. Italy Non-Opioid Pain Treatment Market, by Drug Class
          2. Italy Non-Opioid Pain Treatment Market, by Pain Type
          3. Italy Non-Opioid Pain Treatment Market, by Route of Administration
          4. Italy Non-Opioid Pain Treatment Market, by Distribution Channel
        6. Rest of Europe
          1. Rest of Europe Non-Opioid Pain Treatment Market, by Drug Class
          2. Rest of Europe Non-Opioid Pain Treatment Market, by Pain Type
          3. Rest of Europe Non-Opioid Pain Treatment Market, by Route of Administration
          4. Rest of Europe Non-Opioid Pain Treatment Market, by Distribution Channel
    3. Asia Pacific Non-Opioid Pain Treatment Market
      1. Asia Pacific Non-Opioid Pain Treatment Market, by Drug Class
      2. Asia Pacific Non-Opioid Pain Treatment Market, by Pain Type
      3. Asia Pacific Non-Opioid Pain Treatment Market, by Route of Administration
      4. Asia Pacific Non-Opioid Pain Treatment Market, by Distribution Channel
      5. Asia Pacific Non-Opioid Pain Treatment Market, by Country/Region
        1. China
          1. China Non-Opioid Pain Treatment Market, by Drug Class
          2. China Non-Opioid Pain Treatment Market, by Pain Type
          3. China Non-Opioid Pain Treatment Market, by Route of Administration
          4. China Non-Opioid Pain Treatment Market, by Distribution Channel
        2. Japan
          1. Japan Non-Opioid Pain Treatment Market, by Drug Class
          2. Japan Non-Opioid Pain Treatment Market, by Pain Type
          3. Japan Non-Opioid Pain Treatment Market, by Route of Administration
          4. Japan Non-Opioid Pain Treatment Market, by Distribution Channel
        3. India
          1. India Non-Opioid Pain Treatment Market, by Drug Class
          2. India Non-Opioid Pain Treatment Market, by Pain Type
          3. India Non-Opioid Pain Treatment Market, by Route of Administration
          4. India Non-Opioid Pain Treatment Market, by Distribution Channel
        4. South Korea
          1. South Korea Non-Opioid Pain Treatment Market, by Drug Class
          2. South Korea Non-Opioid Pain Treatment Market, by Pain Type
          3. South Korea Non-Opioid Pain Treatment Market, by Route of Administration
          4. South Korea Non-Opioid Pain Treatment Market, by Distribution Channel
        5. Australia
          1. Australia Non-Opioid Pain Treatment Market, by Drug Class
          2. Australia Non-Opioid Pain Treatment Market, by Pain Type
          3. Australia Non-Opioid Pain Treatment Market, by Route of Administration
          4. Australia Non-Opioid Pain Treatment Market, by Distribution Channel
        6. Rest of Asia Pacific 
          1. Rest of Asia Pacific Non-Opioid Pain Treatment Market, by Drug Class
          2. Rest of Asia Pacific Non-Opioid Pain Treatment Market, by Pain Type
          3. Rest of Asia Pacific Non-Opioid Pain Treatment Market, by Route of Administration
          4. Rest of Asia Pacific Non-Opioid Pain Treatment Market, by Distribution Channel
    4. Latin America Non-Opioid Pain Treatment Market
      1. Latin America Non-Opioid Pain Treatment Market, by Drug Class
      2. Latin America Non-Opioid Pain Treatment Market, by Pain Type 
      3. Latin America Non-Opioid Pain Treatment Market, by Route of Administration
      4. Latin America Non-Opioid Pain Treatment Market, by Distribution Channel 
      5. Latin America Non-Opioid Pain Treatment Market, by Country/ Region
        1. Brazil
          1. Brazil Non-Opioid Pain Treatment Market, by Drug Class
          2. Brazil Non-Opioid Pain Treatment Market, by Pain Type 
          3. Brazil Non-Opioid Pain Treatment Market, by Route of Administration
          4. Brazil Non-Opioid Pain Treatment Market, by Distribution Channel 
        2. Mexico
          1. Mexico Non-Opioid Pain Treatment Market, by Drug Class
          2. Mexico Non-Opioid Pain Treatment Market, by Pain Type 
          3. Mexico Non-Opioid Pain Treatment Market, by Route of Administration 
          4. Mexico Non-Opioid Pain Treatment Market, by Distribution Channel
        3. Argentina
          1. Argentina Non-Opioid Pain Treatment Market, by Drug Class
          2. Argentina Non-Opioid Pain Treatment Market, by Pain Type 
          3. Argentina Non-Opioid Pain Treatment Market, by Route of Administration
          4. Argentina Non-Opioid Pain Treatment Market, by Distribution Channel 
        4. Rest of Latin America
          1. Rest of Latin America Non-Opioid Pain Treatment Market, by Drug Class
          2. Rest of Latin America Non-Opioid Pain Treatment Market, by Pain Type 
          3. Rest of Latin America Non-Opioid Pain Treatment Market, by Route of Administration 
          4. Rest of Latin America Non-Opioid Pain Treatment Market, by Distribution Channel
    5. Middle East & Africa Non-Opioid Pain Treatment Market
      1. Middle East & Africa Non-Opioid Pain Treatment Market, by Drug Class
      2. Middle East & Africa Non-Opioid Pain Treatment Market, by Pain Type 
      3. Middle East & Africa Non-Opioid Pain Treatment Market, by Route of Administration
      4. Middle East & Africa Non-Opioid Pain Treatment Market, by Distribution Channel 
      5. Middle East & Africa a Non-Opioid Pain Treatment Market, by Country/ Region
        1. GCC Countries
          1. GCC Countries Non-Opioid Pain Treatment Market, by Drug Class
          2. GCC Countries Non-Opioid Pain Treatment Market, by Pain Type 
          3. GCC Countries Non-Opioid Pain Treatment Market, by Route of Administration
          4. GCC Countries Non-Opioid Pain Treatment Market, by Distribution Channel 
        2. South Africa
          1. South Africa Non-Opioid Pain Treatment Market, by Drug Class
          2. South Africa Non-Opioid Pain Treatment Market, by Pain Type 
          3. South Africa Non-Opioid Pain Treatment Market, by Route of Administration 
          4. South Africa Non-Opioid Pain Treatment Market, by Distribution Channel
        3. Rest of Middle East & Africa
          1. Rest of Middle East & Africa Non-Opioid Pain Treatment Market, by Drug Class
          2. Rest of Middle East & Africa Non-Opioid Pain Treatment Market, by Pain Type 
          3. Rest of Middle East & Africa Non-Opioid Pain Treatment Market, by Route of Administration
          4. Rest of Middle East & Africa Non-Opioid Pain Treatment Market, by Distribution Channel 
  10. COMPANY PROFILES         
    1. Novartis AG
      1. Business Snapshot 
      2. Products Offered
      3. Financial Details
      4. Strategic Development
    2. Teva Pharmaceutical Industries Limited
    3. Dr. Reddy’s Laboratories Ltd
    4. Sun Pharmaceutical Industries Ltd
    5. GSK Plc.
    6. Pfizer Inc.
    7. Perrigo Company Plc.
    8. LNK International Inc.
    9. Cipla Inc.
    10. Johnson & Johnson Service, Inc.
    11. Pacira Pharmaceuticals Inc.
    12. Pierrel

*Insights on financial performance are subject to the availability of information in the public domain

List of Tables

 

  1. Global Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  2. Global Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  3. Global Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  4. Global Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million)
  5. Global Non-Opioid Pain Treatment Market, by Region, 2021-2031 (US$ Million)  
  6. North America Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  7. North America Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  8. North America Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  9. North America Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  10. North America Non-Opioid Pain Treatment Market, by Country, 2021-2031 (US$ Million) 
  11. U.S. Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  12. U.S. Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  13. U.S. Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  14. U.S. Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  15. Canada Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  16. Canada Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  17. Canada Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  18. Canada Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  19. Europe Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  20. Europe Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  21. Europe Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  22. Europe Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  23. Europe Non-Opioid Pain Treatment Market, by Country/ Region, 2021-2031 (US$ Million) 
  24. Germany Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  25. Germany Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  26. Germany Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  27. Germany Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  28. U.K. Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  29. U.K. Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  30. U.K. Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  31. U.K. Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  32. France Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  33. France Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  34. France Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  35. France Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  36. Italy Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  37. Italy Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  38. Italy Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  39. Italy Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  40. Spain Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  41. Spain Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  42. Spain Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  43. Spain Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  44. Rest of Europe Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  45. Rest of Europe Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  46. Rest of Europe Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  47. Rest of Europe Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  48. Asia Pacific Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  49. Asia Pacific Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  50. Asia Pacific Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  51. Asia Pacific Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  52. Asia Pacific Non-Opioid Pain Treatment Market, by Country/ Region, 2021-2031 (US$ Million) 
  53. China Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  54. China Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  55. China Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  56. China Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million)
  57. Japan Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  58. Japan Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  59. Japan Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  60. Japan Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  61. India Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  62. India Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  63. India Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  64. India Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  65. South Korea Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  66. South Korea Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  67. South Korea Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  68. South Korea Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  69. Australia Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  70. Australia Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  71. Australia Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  72. Australia Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million) 
  73. Rest of Asia Pacific Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  74. Rest of Asia Pacific Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million)
  75. Rest of Asia Pacific Non-Opioid Pain Treatment Market, by Route of Administration, 2021-2031 (US$ Million)
  76. Rest of Asia Pacific Non-Opioid Pain Treatment Market, by Distribution Channel, 2021-2031 (US$ Million)
  77. Latin America Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  78. Latin America Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million) 
  79. Latin America Non-Opioid Pain Treatment Market, by Route of Administration, 2021–2031 (US$ Million) 
  80. Latin America Non-Opioid Pain Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  81. Latin America Non-Opioid Pain Treatment Market, by Country/ Region, 2021–2031 (US$ Million)
  82. Brazil Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million) 
  83. Brazil Non-Opioid Pain Treatment Market, by Route of Administration, 2021–2031 (US$ Million) 
  84. Brazil Non-Opioid Pain Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  85. Mexico Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  86. Mexico Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million) 
  87. Mexico Non-Opioid Pain Treatment Market, by Route of Administration, 2021–2031 (US$ Million) 
  88. Mexico Non-Opioid Pain Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  89. Argentina Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  90. Argentina Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million) 
  91. Argentina Non-Opioid Pain Treatment Market, by Route of Administration, 2021–2031 (US$ Million) 
  92. Argentina Non-Opioid Pain Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  93. Rest of Latin America Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  94. Rest of Latin America Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million) 
  95. Rest of Latin America Non-Opioid Pain Treatment Market, by Route of Administration, 2021–2031 (US$ Million) 
  96. Rest of Latin America Non-Opioid Pain Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)
  97. Middle East and Africa Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  98. Middle East and Africa Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million) 
  99. Middle East and Africa Non-Opioid Pain Treatment Market, by Route of Administration, 2021–2031 (US$ Million) 
  100. Middle East and Africa Non-Opioid Pain Treatment Market, by Distribution Channel 2021–2031 (US$ Million)
  101. Middle East and Africa Non-Opioid Pain Treatment Market, by Country/ Region, 2021–2031 (US$ Million)
  102. GCC Countries Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  103. GCC Countries Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million) 
  104. GCC Countries Non-Opioid Pain Treatment Market, by Route of Administration, 2021–2031 (US$ Million) 
  105. GCC Countries Non-Opioid Pain Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  106. South Africa Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  107. South Africa Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million) 
  108. South Africa Non-Opioid Pain Treatment Market, by Route of Administration, 2021–2031 (US$ Million) 
  109. South Africa Non-Opioid Pain Treatment Market, by Distribution Channel, 2021–2031 (US$ Million) 
  110. Rest of Middle East & Africa Non-Opioid Pain Treatment Market, by Drug Class, 2021-2031 (US$ Million)
  111. Rest of Middle East & Africa Non-Opioid Pain Treatment Market, by Pain Type, 2021-2031 (US$ Million) 
  112. Rest of Middle East & Africa Non-Opioid Pain Treatment Market, by Route of Administration, 2021–2031 (US$ Million) 
  113. Rest of Middle East & Africa Non-Opioid Pain Treatment Market, by Distribution Channel, 2021–2031 (US$ Million)

List of Figures

 

  1. Non-Opioid Pain Treatment Market Ecosystem  
  2. Snapshot of Global Non-Opioid Pain Treatment Market, 2021-2031
  3. Snapshot of Global Non-Opioid Pain Treatment Market, by Region, 2021-2031 
  4. Global Non-Opioid Pain Treatment Market: COVID-19 Pandemic Impact Assessment 
  5. Global Non-Opioid Pain Treatment Market: Key Players & Competitive Positioning (2021) 
  6. Non-Opioid Pain Treatment: Market Dynamics 
  7. Global Non-Opioid Pain Treatment Market for NSAIDs, 2021-2031 (US$ Million) 
  8. Global NSAIDs Market for Selective COX-2 Inhibitors, 2021-2031 (US$ Million) 
  9. Global NSAIDs Market for Non-Selective NSAIDs, 2021-2031 (US$ Million)
  10. Global Non-Opioid Pain Treatment Market for Acetaminophen, 2021-2031 (US$ Million) 
  11. Global Non-Opioid Pain Treatment Market for Local Anesthetics, 2021-2031 (US$ Million)
  12. Global Non-Opioid Pain Treatment Market for Others, 2021-2031 (US$ Million)
  13. Global Non-Opioid Pain Treatment Market for Chronic Pain, 2021-2031 (US$ Million)
  14. Global Chronic Pain Market for Neuropathic Pain, 2021-2031 (US$ Million)
  15. Global Chronic Pain Market for Inflammatory Conditions, 2021-2031 (US$ Million)
  16. Global Non-Opioid Pain Treatment Market for Post-operative Pain, 2021-2031 (US$ Million)
  17. Global Non-Opioid Pain Treatment Market for Cancer, 2021-2031 (US$ Million) 
  18. Global Non-Opioid Pain Treatment Market for Others, 2021-2031 (US$ Million)
  19. Global Non-Opioid Pain Treatment Market for Oral, 2021-2031 (US$ Million)
  20. Global Non-Opioid Pain Treatment Market for Injectable, 2021-2031 (US$ Million)
  21. Global Non-Opioid Pain Treatment Market for Topical, 2021-2031 (US$ Million)
  22. Global Non-Opioid Pain Treatment Market for Others, 2021-2031 (US$ Million)
  23. Global Non-Opioid Pain Treatment Market for Hospital Pharmacies, 2021-2031 (US$ Million)
  24. Global Non-Opioid Pain Treatment Market for Retail Pharmacies, 2021-2031 (US$ Million)
  25. Global Non-Opioid Pain Treatment Market for Online Pharmacies, 2021-2031 (US$ Million)
  26. North America Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  27. U.S. Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  28. Canada Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  29. Europe Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  30. Germany Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  31. U.K. Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  32. France Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  33. Italy Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  34. Spain Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  35. Rest of Europe Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  36. Asia Pacific Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  37. China Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  38. Japan Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  39. India Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  40. South Korea Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  41. Australia Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  42. Rest of Asia Pacific Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  43. Latin America Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  44. Brazil Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  45. Mexico Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  46. Argentina Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million)
  47. Rest of Latin America Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million)
  48. Middle East & Africa Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  49. GCC Countries Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  50. South Africa Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  51. Rest of Middle East & Africa Non-Opioid Pain Treatment Market, 2021-2031 (US$ Million) 
  52. AbbVie Inc. Revenue from 2019 Onwards (US$ Million)
  53. Novartis AG Revenue from 2019 Onwards (US$ Million)
  54. Teva Pharmaceutical Industries Limited Revenue from 2019 Onwards (US$ Million)
  55. Dr. Reddy’s Laboratories Ltd Revenue from 2019 Onwards (US$ Million)
  56. Sun Pharmaceutical Industries Ltd Revenue from 2019 Onwards (US$ Million)
  57. GSK Plc. Revenue from 2019 Onwards (US$ Million)
  58. Pfizer Inc. Revenue from 2019 Onwards (US$ Million)
  59. Perrigo Company Plc. Revenue from 2019 Onwards (US$ Million)
  60. LNK International Inc. Revenue from 2019 Onwards (US$ Million)
  61. Cipla Inc. Revenue from 2019 Onwards (US$ Million)
  62. Johnson & Johnson Services Inc. Revenue from 2019 Onwards (US$ Million)
  63. Pacira Pharmaceuticals Inc. Revenue from 2019 Onwards (US$ Million)
  64. Pierrel Revenue from 2019 Onwards (US$ Million)

Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Non-Opioid Pain Treatment Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Non-Opioid Pain Treatment Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports